Blood Pressure Heart Attack Pharmacology 
DAIC
APRIL 7, 2024
Akshay Desai, MD “Compared to placebo, a single injection of zilebesiran resulted in clinically meaningful reductions in blood pressure at three months when added to commonly used antihypertensive treatments,” said Akshay Desai, MD, MPH , a cardiologist at Brigham and Women’s Hospital in Boston and a study coauthor. “In
Dr. Paddy Barrett
APRIL 5, 2024
Primary prevention is the management of the risk factors, e.g. high blood pressure, early in life to prevent complications of the condition, i.e. coronary artery disease. This refers to all the steps necessary to reduce the odds of a subsequent event, such as a second heart attack or stroke. Secondary prevention.
DAIC
MAY 21, 2024
A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. Of 102,475 participants, 49.1%
DAIC
MAY 16, 2024
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).
DAIC
JANUARY 23, 2024
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 21 Luckily, each of these risks can be measured by simple blood tests. 4 In the U.S. 22 In general, hsCRP values above 2.0
Expert insights. Personalized for you.
111 
Let's personalize your content